NASDAQ : VTVT
vTv Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 25.17 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 312.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
vTv Therapeutics Inc. (VTVT) reported revenue of 36.84M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 36.84M | 1.02M | 2.02M | 4.00M | ||
| Cost of Revenue | 28.68M | 17.86M | 11.55M | 13.60M | 12.36M | 12.62M |
| Gross Profit | 8.16M | -17.86M | -10.53M | -13.60M | -10.34M | -8.62M |
| Selling, General & Admin | 17.41M | 14.95M | 13.65M | 11.91M | 12.20M | 11.44M |
| Operating Expenses | 17.41M | 14.95M | 13.65M | 11.91M | 12.20M | 11.44M |
| Operating Income | -9.25M | -32.81M | -24.18M | -25.50M | -22.54M | -20.06M |
| Interest Expense | -6.00K | -6.00K | -13.00K | -15.00K | -12.00K | |
| Interest & Investment Income | 2.91M | 1.87M | 1.56M | 472.00K | 352.00K | 1.00K |
| Other Non Operating Income (Expenses) | -60.00K | -136.00K | 10.00K | 574.00K | 915.00K | 1.61M |
| EBT Excluding Unusual Items | -6.40M | -31.08M | -22.61M | -24.47M | -21.29M | -18.46M |
| Merger & Restructuring Charges | -1.60M | |||||
| Gain (Loss) on Sale of Investments | -1.18M | -3.58M | 2.45M | |||
| Other Unusual Items | -313.00K | |||||
| Pretax Income | -6.40M | -31.08M | -22.61M | -25.97M | -24.87M | -17.62M |
| Income Tax Expense | 100.00K | 200.00K | 115.00K | |||
| Earnings From Continuing Operations | -6.40M | -31.08M | -22.70M | -25.97M | -25.07M | -17.73M |
| Minority Interest in Earnings | 1.65M | 4.11M | 4.24M | 5.72M | 5.91M | 4.74M |
| Net Income | -4.76M | -26.97M | -18.46M | -20.25M | -19.16M | -12.99M |
| Net Income to Common | -4.76M | -26.97M | -18.46M | -20.25M | -19.16M | -12.99M |
| Shares Outstanding (Basic) | 11.34M | 8.42M | 5.77M | 2.08M | 1.92M | 1.57M |
| Shares Outstanding (Diluted) | 11.34M | 8.42M | 5.77M | 2.08M | 1.92M | 1.57M |
| EPS (Basic) | -0.42 | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 |
| EPS (Diluted) | -0.42 | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 |
| Free Cash Flow | -16.76M | -25.25M | -25.31M | -19.08M | -16.04M | -19.31M |
| Free Cash Flow Per Share | -1.48 | -3.00 | -4.38 | -9.15 | -8.36 | -12.33 |
| Gross Margin | 22.16% | -215.21% | ||||
| Operating Margin | -25.11% | -2,377.58% | -1,116.95% | -500.92% | ||
| Profit Margin | -12.91% | -1,815.34% | -949.65% | -324.27% | ||
| Free Cash Flow Margin | -45.50% | -2,488.40% | -795.00% | -482.10% | ||
| EBITDA | -9.24M | -32.79M | -24.09M | -25.41M | -22.45M | -19.97M |
| EBITDA Margin | -25.10% | |||||
| D&A For EBITDA | 6.00K | 16.00K | 89.00K | 90.00K | 92.00K | 89.00K |
| EBIT | -9.25M | -32.81M | -24.18M | -25.50M | -22.54M | -20.06M |
| EBIT Margin | -25.11% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 86.64M | 88.93M | 36.75M | 9.45M | 12.13M | 13.41M |
| Short-Term Investments | 65.00K | 15.00K | 100.00K | |||
| Cash & Short-Term Investments | 86.64M | 88.93M | 36.75M | 9.51M | 12.14M | 13.52M |
| Accounts Receivable | 102.00K | 173.00K | 57.00K | |||
| Other Receivables | 135.00K | |||||
| Receivables | 102.00K | 12.42M | 192.00K | |||
| Prepaid Expenses | 416.00K | 626.00K | 1.15M | 1.04M | 2.54M | 1.91M |
| Other Current Assets | 530.00K | 335.00K | 218.00K | |||
| Total Current Assets | 87.59M | 89.89M | 38.11M | 10.66M | 27.09M | 15.62M |
| Property, Plant & Equipment | 361.00K | 556.00K | 680.00K | |||
| Long-Term Investments | 5.59M | 9.17M | ||||
| Other Long-Term Assets | 4.00K | 6.00K | 153.00K | |||
| Total Assets | 87.59M | 89.90M | 38.27M | 11.02M | 33.24M | 25.47M |
| Accounts Payable | 6.99M | 1.13M | 939.00K | 4.08M | 2.46M | 1.88M |
| Accrued Expenses | 5.42M | 4.09M | 6.17M | 4.85M | 6.15M | |
| Short-Term Debt | 191.00K | 224.00K | 256.00K | |||
| Current Portion of Leases | 169.00K | 169.00K | 154.00K | 184.00K | ||
| Current Unearned Revenue | 17.00K | 17.00K | 35.00K | |||
| Other Current Liabilities | 25.00K | 84.00K | ||||
| Total Current Liabilities | 7.02M | 6.64M | 5.20M | 10.62M | 7.71M | 8.50M |
| Long-Term Leases | 169.00K | 338.00K | 492.00K | |||
| Long-Term Unearned Revenue | 1.83M | 18.67M | 18.67M | 18.67M | 18.67M | |
| Other Long-Term Liabilities | 114.00K | 152.00K | 100.00K | 110.00K | 684.00K | 1.26M |
| Total Liabilities | 8.96M | 25.46M | 23.96M | 29.57M | 27.40M | 10.25M |
| Common Stock | 39.00K | 39.00K | 32.00K | 27.00K | 27.00K | 901.00K |
| Additional Paid-In Capital | 394.20M | 391.09M | 311.88M | 256.33M | 254.76M | 238.19M |
| Retained Earnings | -315.61M | -326.69M | -299.72M | -281.04M | -265.52M | -248.83M |
| Total Common Equity | 78.63M | 64.44M | 12.20M | -24.68M | -10.74M | -9.74M |
| Minority Interest | 2.10M | 6.13M | 16.58M | 24.96M | ||
| Shareholders' Equity | 78.63M | 64.44M | 14.30M | -18.55M | 5.84M | 15.22M |
| Total Liabilities & Equity | 87.59M | 89.90M | 38.27M | 11.02M | 33.24M | 25.47M |
| Total Debt | 169.00K | 529.00K | 716.00K | 932.00K | ||
| Net Cash (Debt) | 86.64M | 88.93M | 36.58M | 8.98M | 11.43M | 12.58M |
| Net Cash Per Share | 7.64 | 10.56 | 6.34 | 4.31 | 5.95 | 8.03 |
| Filing Date Shares Outstanding | 12.42M | 12.41M | 6.58M | 2.43M | 2.04M | 1.67M |
| Total Common Shares Outstanding | 12.41M | 12.41M | 6.58M | 2.08M | 2.04M | 1.67M |
| Working Capital | 80.57M | 83.25M | 32.92M | 38.00K | 19.39M | 7.12M |
| Book Value Per Share | 6.34 | 5.19 | 1.85 | -11.84 | -5.27 | -5.82 |
| Tangible Book Value | 78.63M | 64.44M | 12.20M | -24.68M | -10.74M | -9.74M |
| Tangible Book Value Per Share | 6.34 | 5.19 | 1.85 | -11.84 | -5.27 | -5.82 |
| Machinery | 118.00K | 118.00K | 97.00K | |||
| Leasehold Improvements | 406.00K | 406.00K | 406.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -4.76M | -26.97M | -18.46M | -20.25M | -19.16M | -12.99M |
| Depreciation & Amortization | 6.00K | 16.00K | 89.00K | 90.00K | 92.00K | 89.00K |
| Loss (Gain) From Sale of Assets | 6.00K | 6.00K | ||||
| Loss (Gain) From Sale of Investments | 1.18M | 3.58M | -2.45M | |||
| Stock-Based Compensation | 5.15M | 3.77M | 2.76M | 1.58M | 1.27M | 2.36M |
| Other Operating Activities | -1.59M | -3.97M | -4.25M | -6.08M | -7.19M | -6.35M |
| Change in Accounts Receivable | -116.00K | 101.00K | ||||
| Change in Accounts Payable | 1.78M | 1.53M | -5.21M | 2.93M | -856.00K | 1.83M |
| Change in Unearned Revenue | -16.84M | -17.00K | 6.76M | -1.00M | ||
| Change in Other Net Operating Assets | -515.00K | 362.00K | -206.00K | 1.47M | -403.00K | -889.00K |
| Operating Cash Flow | -16.76M | -25.25M | -25.31M | -19.08M | -16.02M | -19.31M |
| Capital Expenditures | -21.00K | |||||
| Investment in Securities | 4.40M | |||||
| Investing Cash Flow | 4.40M | -21.00K | ||||
| Long-Term Debt Issued | 392.00K | 566.00K | 776.00K | 887.00K | ||
| Short-Term Debt Repaid | -808.00K | |||||
| Long-Term Debt Repaid | -392.00K | -191.00K | -599.00K | -715.00K | ||
| Total Debt Repaid | -392.00K | -392.00K | -191.00K | -599.00K | -808.00K | -715.00K |
| Net Debt Issued (Repaid) | -191.00K | -33.00K | -32.00K | 172.00K | ||
| Issuance of Common Stock | 77.48M | 77.49M | 52.80M | 12.03M | 14.79M | 26.80M |
| Repurchase of Common Stock | -51.00K | |||||
| Financing Cash Flow | 77.48M | 77.44M | 52.61M | 12.00M | 14.75M | 26.98M |
| Net Cash Flow | 60.72M | 52.19M | 27.30M | -2.68M | -1.29M | 7.67M |
| Free Cash Flow | -16.76M | -25.25M | -25.31M | -19.08M | -16.04M | -19.31M |
| Free Cash Flow Margin | -45.50% | -2,488.40% | -795.00% | -482.10% | ||
| Free Cash Flow Per Share | -1.48 | -3.00 | -4.38 | -9.15 | -8.36 | -12.33 |
| Levered Free Cash Flow | 674.38K | -14.70M | -17.72M | 2.46M | -26.33M | -9.20M |
| Unlevered Free Cash Flow | 678.12K | -14.69M | -17.72M | 2.47M | -26.32M | -9.20M |
| Cash Interest Paid | 6.00K | 6.00K | 2.00K | 14.00K | 15.00K | 11.00K |
| Cash Income Tax Paid | 100.00K | 200.00K | 115.00K | |||
| Change in Working Capital | -15.58M | 1.89M | -5.44M | 4.39M | 5.38M | 35.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 300.06M | 496.22M | 90.90M | 23.43M | 54.01M | 66.61M |
| Enterprise Value | 213.41M | 398.08M | 52.36M | 26.75M | 63.96M | 92.90M |
| Last Close Price | 25.17 | 39.99 | 13.81 | 11.50 | 26.51 | 39.80 |
| PS Ratio | 8.18 | 89.38 | 26.76 | 16.63 | ||
| PB Ratio | 3.97 | 7.70 | 6.36 | -1.26 | 9.25 | 4.38 |
| P/TBV Ratio | 3.83 | 7.70 | 7.45 | |||
| EV/Sales Ratio | 5.83 | 51.49 | 31.69 | 23.20 | ||
| Debt / Equity Ratio | 0.01 | -0.03 | 0.12 | 0.06 | ||
| Net Debt / Equity Ratio | -1.10 | -1.38 | -2.56 | 0.48 | -1.96 | -0.83 |
| Net Debt / EBITDA Ratio | 9.37 | 2.71 | 1.52 | 0.35 | 0.51 | 0.63 |
| Net Debt / FCF Ratio | 5.17 | 3.52 | 1.45 | 0.47 | 0.71 | 0.65 |
| Asset Turnover | 0.65 | 0.04 | 0.07 | 0.20 | ||
| Quick Ratio | 12.35 | 13.39 | 7.07 | 0.91 | 1.60 | 1.61 |
| Current Ratio | 12.48 | 13.54 | 7.33 | 1.00 | 3.52 | 1.84 |
| Return on Equity (ROE) | -15.80% | -78.94% | -238.10% | -186.50% | ||
| Return on Assets (ROA) | -10.14% | -32.00% | -61.33% | -72.03% | -47.99% | -62.28% |
| Return on Capital Employed (ROCE) | -11.50% | -39.40% | -73.10% | -6,391.50% | -88.30% | -118.20% |
| Earnings Yield | -1.75% | -5.44% | -20.31% | -86.44% | -35.48% | -19.50% |
| FCF Yield | -5.56% | -5.09% | -27.84% | -81.45% | -29.70% | -28.99% |
| Buyback Yield / Dilution | -74.02% | -45.96% | -176.79% | -8.60% | -22.58% | -32.90% |